Maple Health Group, LLC

Background

Founded in 2015, Maple Health Group, LLC is a boutique global strategy consulting firm headquartered in New York City. The company specializes in providing strategic market access and Health Economics and Outcomes Research (HEOR) insights across all phases of an asset's development.

Key Strategic Focus

Maple Health Group's core competencies include:

Health Economic Modelling: Developing cost-effectiveness and budget impact models to demonstrate product value.

Interactive Payer Tool Development: Creating tools to facilitate payer engagement and decision-making.

Health Technology Assessment (HTA) and Reimbursement Strategy: Crafting strategies to navigate HTA processes and optimize reimbursement outcomes.

Value Proposition Development and Testing: Formulating and validating value propositions to support market access.

The firm operates via a network-based consortium model, integrating experienced research partners across various disciplines, including statisticians, health economists, country-specific market access experts, and medical writers. This approach enables seamless service delivery through a single point of contact for clients.

Financials and Funding

As of June 2025, Maple Health Group's estimated annual revenue is approximately $11.9 million. The company employs around 53 individuals, with an average revenue per employee of $223,800.

Technological Platform and Innovation

Maple Health Group leverages a network-based consortium model, integrating experienced research partners across various disciplines. This model allows the firm to provide comprehensive and specialized services tailored to client needs.

Leadership Team

Rachel Beckerman, Ph.D.: Founder and Managing Partner. Dr. Beckerman brings extensive experience in market access and HEOR consulting, leading the firm's strategic direction and client engagements.

Dennis Meletiche: Partner. Mr. Meletiche contributes his expertise in market access strategies and client relationship management.

Nathaniel Smith, Ph.D.: Partner. Dr. Smith specializes in health economics and outcomes research, overseeing the development of economic models and evidence synthesis projects.

Competitor Profile

Market Insights and Dynamics

The pharmaceutical consulting industry is characterized by a growing demand for specialized services in market access, health economics, and outcomes research. Companies in this sector assist pharmaceutical, biotech, and medical device firms in navigating complex regulatory environments and optimizing product value propositions.

Competitor Analysis

Key competitors include:

Hikma Pharmaceuticals: Focuses on a wide range of generic and branded generic pharmaceutical products.

Sun Pharma: Develops generic prescription products in various dosage forms.

Torrent Pharmaceuticals: Manufactures a wide range of pharmaceutical products.

Divis Laboratories: Specializes in developing processes for the production of Active Pharmaceutical Ingredients (APIs) and intermediates.

Strategic Collaborations and Partnerships

Maple Health Group operates through a network-based consortium model, collaborating with experienced research partners across various disciplines. This approach enables the firm to offer comprehensive and specialized services tailored to client needs.

Operational Insights

The firm's network-based consortium model and diverse team of experts provide a competitive advantage by offering clients a seamless and integrated consulting experience. This approach allows Maple Health Group to address complex challenges in market access and health economics effectively.

Strategic Opportunities and Future Directions

Maple Health Group aims to expand its global presence and enhance its service offerings by leveraging its network-based consortium model. The firm is committed to staying at the forefront of industry trends and providing clients with innovative solutions to optimize market access and demonstrate product value.